Framingham, MA, United States of America

Michael Louis Miller

This inventor holds 57 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 13 EPO patents, primarily in Cytotoxic Benzodiazepines (CPC class A61K). Top assignees: Immunogen, Inc., Aventis Pharma S.a., Other. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Louis Miller. Retrieved from https://idiyas.com/inventor/michael-louis-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 (Patent Applications = 15)

% Patents Active = 71.9

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 23)

Average Co-Inventor Count = 3.4

ph-index = 12

Forward Citations = 734(Granted Patents)

Forward Citations (Not Self Cited) = 489(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Greenacres, WA (US) (1989)
Somerville, MA (US) (2003 - 2004)
Framington, MA (US) (2014)
Santa Cruz, CA (US) (2017 - 2019)
Framingham, MA (US) (2008 - 2024)

Company Filing History:

3 out of 834,453

Other

patents

Years Active: 1989-2024

Loading Chart...

Areas of Expertise:

Cytotoxic Agents

Benzodiazepine Derivatives

Cell-Binding Agents

Proliferative Disorders

Substituted Indolines

Conjugates

Antibody Engineering

3D Stereoscopic Camera

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981687 - Methods of preparing cytotoxic benzodiazepine derivatives (2024-05-14),

2. RE49918 - Cytotoxic benzodiazepine derivatives (2024-04-16),

3. 11793885 - Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders (2023-10-24),

4. 11760759 - Process for preparing substituted indolines (2023-09-19),

5. 11732038 - Conjugates comprising cell-binding agents and cytotoxic agents (2023-08-22),

6. 11505617 - Benzodiazepine derivatives (2022-11-22),

7. 11420982 - Methods of preparing cytotoxic benzodiazepine derivatives (2022-08-23),

8. 11390633 - Methods of preparing cytotoxic benzodiazepine derivatives (2022-07-19),

9. 11116845 - Cytotoxic benzodiazepine derivatives (2021-09-14),

10. 10988531 - Conjugates comprising cell-binding agents and cytotoxic agents (2021-04-27),

11. 10968228 - Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indoles (2021-04-06),

12. 10947315 - Benzodiazepine derivatives (2021-03-16),

13. 10899775 - Methods of preparing cytotoxic benzodiazepine derivatives (2021-01-26),

14. 10898579 - Conjugates of cysteine engineered antibodies (2021-01-26),

15. 10844078 - Methods of preparing cytotoxic benzodiazepine derivatives (2020-11-24),

Title: The Innovative Journey of Michael Louis Miller

Introduction: Michael Louis Miller, a visionary inventor hailing from Framingham, MA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Michael Louis Miller's latest patents include a cutting-edge wearable technology device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Michael Louis Miller has established himself as a pioneer in the field of wearable technology, holding multiple patents in the areas of healthcare, communication, and consumer electronics.

Collaborations: Throughout his career, Michael Louis Miller has collaborated with leading research institutions and tech companies to bring his innovative ideas to life. His partnerships have resulted in the development of products that have positively impacted the lives of many.

Conclusion: Michael Louis Miller's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors. His contributions to the field of wearable technology have cemented his legacy as a true trailblazer in the industry.

Profile summary based on public USPTO records.